MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s10147-026-03203-y

Медицинская библиотека · International journal of clinical oncology · 2026

Pharmacotherapy for older adults with cancer: a digest of the Japanese clinical practice guidelines (2nd edition)-gastrointestinal cancers.

Ishibashi Naoya, Ueno Masayuki, Kataoka Shigeki, Doi Ayako, Tanaka Chie, Maeda Osamu, Hamaguchi Tetsuya, Nakazawa Junichi, Nagashima Fumio, Matsuoka Ayumu, Makiyama Akitaka, JSMO/JSCO Clinical Practice Guideline Committee for Pharmacotherapy in Older Adults with Cancer

СтатьяПеревод в очереди

Аннотация

BACKGROUND

The number of older adults with gastrointestinal cancers is increasing in rapidly aging societies. However, optimal pharmacotherapy for this population remains challenging because of heterogeneity in functional status, comorbidities, and the limited representation of older patients in clinical trials.

METHODS

This article presents an English digest of the Japanese Clinical Practice Guidelines for Pharmacotherapy in Older Adults with Cancer (second edition) [5] with a focus on gastrointestinal cancers. The guidelines were developed in accordance with the Minds 2020 methodology, incorporating systematic reviews, the Evidence-to-Decision framework, and multidisciplinary consensus.

RESULTS

The guideline addresses key clinical questions regarding systemic therapy for older patients with gastric and colorectal cancers, including combination chemotherapy, biomarker-guided therapy, and adjuvant treatment strategies. All recommendations were conditional because of limited direct evidence in older populations. Specifically, in gastric cancer, oxaliplatin-containing combination therapy and biomarker-guided treatment may be considered for appropriately selected patients and are conditionally recommended. In colorectal cancer, routine treatment intensification with oxaliplatin- or irinotecan-containing regimens is not uniformly recommended. Treatment decisions should be individualized by weighing the expected benefit against the risk of increased toxicity, particularly in frail or very old patients.

CONCLUSIONS

These guidelines provide practical evidence-informed recommendations for pharmacotherapy in older adults with gastrointestinal cancers. They emphasize individualized treatment strategies that integrate patient characteristics, treatment goals, and tolerability. Further research, specifically targeting older populations, is required to strengthen the evidence base in geriatric oncology.

Для цитирования: Ishibashi Naoya, Ueno Masayuki, Kataoka Shigeki, Doi Ayako, Tanaka Chie, Maeda Osamu, Hamaguchi Tetsuya, Nakazawa Junichi, Nagashima Fumio, Matsuoka Ayumu, Makiyama Akitaka, JSMO/JSCO Clinical Practice Guideline Committee for Pharmacotherapy in Older Adults with Cancer. Pharmacotherapy for older adults with cancer: a digest of the Japanese clinical practice guidelines (2nd edition)-gastrointestinal cancers.. International journal of clinical oncology. 2026. DOI: 10.1007/s10147-026-03203-y.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.